Patel Samir Rashmikant

CIK 00017024472 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001702447

Recent Transactions

40 trades

Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase American Depositary Shares ("ADRs")
2025-12-16+618,658→ 618,658 total
Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+618,658→ 618,658 total
Purchase
Akari Therapeutics Plc$AKTX
Warrants to purchase ADRs
2025-12-16+231,997→ 231,997 total
Purchase
Akari Therapeutics Plc$AKTX
Pre-Funded Warrants to purchase ADRs
2025-12-16$0.40/sh+231,997→ 231,997 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+175,000→ 175,000 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-03-20+225,000→ 225,000 total
Award
Akari Therapeutics Plc$AKTX
Series B Warrants (Right to Buy)
2025-03-06$1.12/sh+406,250→ 406,250 total
Award
Akari Therapeutics Plc$AKTX
Series A Warrants (Right to Buy)
2025-03-06$1.12/sh+406,250→ 406,250 total
Award
Akari Therapeutics Plc$AKTX
American Depositary Shares representing Ordinary Shares
2025-03-06$1.12/sh+406,250→ 3,031,005 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2025-01-03+152,672,000→ 152,672,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2025-01-03$0.00/sh+208,000→ 5,249,511,500 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-27$0.00/sh+400,000→ 5,249,303,500 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-26$0.00/sh+3,200,000→ 5,248,903,500 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-24$0.00/sh+7,500,000→ 5,245,703,500 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-23$0.00/sh+1,400,000→ 5,238,203,500 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-20$0.00/sh+1,400,000→ 5,236,803,500 total
Award
Akari Therapeutics Plc$AKTX
Warrants (Right to Buy)
2024-12-02$0.00/sh+419,286,000→ 419,286,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-12-02$0.00/sh+419,286,000→ 5,235,403,500 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2024-11-30+162,604,000→ 162,604,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-11-14+1,404,622,000→ 4,816,117,500 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2024-10-31+79,684,000→ 79,684,000 total
Award
Akari Therapeutics Plc$AKTX
Stock Option (Right to Buy)
2024-09-30+175,080,000→ 175,080,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-06-30+91,396,000→ 91,396,000 total
Award
Akari Therapeutics Plc$AKTX
Warrants (Right to Buy)
2024-05-31$0.00/sh+1,326,258,000→ 1,326,258,000 total
Award
Akari Therapeutics Plc$AKTX
Ordinary Shares, par value $0.0001 per share
2024-05-31$0.00/sh+1,326,258,000→ 3,411,495,500 total
Disposition to Issuer
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24−12,329→ 0 total
Award
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24+12,329→ 12,329 total
Disposition to Issuer
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24−225,000→ 0 total
Award
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24+112,500→ 112,500 total
Disposition to Issuer
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24−225,000→ 0 total
Award
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24+225,000→ 225,000 total
Disposition to Issuer
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24−225,000→ 0 total
Award
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24+93,750→ 93,750 total
Award
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24+225,000→ 225,000 total
Disposition to Issuer
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24−12,329→ 0 total
Disposition to Issuer
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24−225,000→ 0 total
Award
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-11-24+12,329→ 12,329 total
Award
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2021-10-18+225,000→ 225,000 total
Award
CytoDyn Inc.$CYDY
Non-qualified Stock Option
2020-06-25+225,000→ 225,000 total
Award
CytoDyn Inc.$CYDY
Stock Option
2020-04-17$2.25/sh+12,329→ 12,329 total

Companies

Recent Filings

Address

C/O AKARI THERAPEUTICS, PLC 22 BOSTON WHARF ROAD FL 7

BOSTON, MA, 02210

View on SEC.gov